295 related articles for article (PubMed ID: 19684511)
21. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.
Tsagarakis NJ; Kentrou NA; Papadimitriou KA; Pagoni M; Kokkini G; Papadaki H; Pappa V; Marinakis T; Anagnostopoulos NI; Vadikolia C; Anagnostopoulos A; Angelopoulou MK; Terpos E; Poziopoulos C; Anargyrou K; Rontogianni D; Papadaki T; Psarra A; Kontopidou FN; Skoumi D; Papadhimitriou SI; Paterakis G;
Leuk Res; 2010 Apr; 34(4):438-46. PubMed ID: 19793612
[TBL] [Abstract][Full Text] [Related]
22. BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM --A RAPIDLY EVOLVING ENTITY. CASE REPORT.
Andrese E; Solovăstru LG; Dimofte G; Ferariu D; Porumb V; Vâţă D; Iancul LS
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):379-83. PubMed ID: 26204640
[TBL] [Abstract][Full Text] [Related]
23. Early plasmacytoid dendritic cell leukemia/lymphoma coexpressing myeloid antigenes.
Giagounidis AA; Heinsch M; Haase S; Aul C
Ann Hematol; 2004 Nov; 83(11):716-21. PubMed ID: 15316755
[TBL] [Abstract][Full Text] [Related]
24. [Blastic plasmacytoid dendritic cell neoplasm: two case reports].
Kaabar M; Lemaire P; Laribi K; Sandrini J; Pineau-Vincent F
Ann Biol Clin (Paris); 2015; 73(6):733-6. PubMed ID: 26553703
[TBL] [Abstract][Full Text] [Related]
25. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
Urosevic M; Conrad C; Kamarashev J; Asagoe K; Cozzio A; Burg G; Dummer R
Hum Pathol; 2005 Sep; 36(9):1020-4. PubMed ID: 16153467
[TBL] [Abstract][Full Text] [Related]
26. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells.
Jacob MC; Chaperot L; Mossuz P; Feuillard J; Valensi F; Leroux D; Béné MC; Bensa JC; Brière F; Plumas J
Haematologica; 2003 Aug; 88(8):941-55. PubMed ID: 12935983
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm.
Dargent JL; Delannoy A; Pieron P; Husson B; Debecker C; Petrella T
J Cutan Pathol; 2011 Nov; 38(11):893-8. PubMed ID: 21883371
[TBL] [Abstract][Full Text] [Related]
28. Blastic plasmacytoid dendritic cell neoplasm: evolving insights in an aggressive hematopoietic malignancy with a predilection of skin involvement.
Gera S; Dekmezian MS; Duvic M; Tschen JA; Vega F; Cho-Vega JH
Am J Dermatopathol; 2014 Mar; 36(3):244-51. PubMed ID: 24247574
[TBL] [Abstract][Full Text] [Related]
29. CD56+ lymphoma with skin involvement: clinicopathologic features and classification.
Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V
Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371
[TBL] [Abstract][Full Text] [Related]
30. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
[TBL] [Abstract][Full Text] [Related]
31. Alpha-interferon secreting blastic plasmacytoid dendritic cells neoplasm: a case report with histological, molecular genetics and long-term tumor cells culture studies.
Petrella T; Hervé G; Bonnotte B; Girodon F; Carlson JA; Bour JB; Lebon P; Mugneret F; Callier P
Am J Dermatopathol; 2012 Aug; 34(6):626-31. PubMed ID: 22534638
[TBL] [Abstract][Full Text] [Related]
32. CD4+/CD56+ haematodermic neoplasm: a preculsor haematological neoplasm that frequently first presents in the skin.
Martín JM; Nicolau MJ; Galán A; Ferrández-Izquierdo A; Ferrer AM; Jordá E
J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1129-32. PubMed ID: 16987271
[TBL] [Abstract][Full Text] [Related]
33. Plasmacytoid dendritic cell leukemia: a rapidly evolving disease presenting with skin lesions sensitive to radiotherapy plus hyperthermia.
Tecchio C; Colato C; Bonifacio M; Krampera M; Maluta S; Pizzolo G; Girolomoni G
Oncologist; 2009 Dec; 14(12):1205-8. PubMed ID: 19939893
[TBL] [Abstract][Full Text] [Related]
34. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.
Rauh MJ; Rahman F; Good D; Silverman J; Brennan MK; Dimov N; Liesveld J; Ryan DH; Burack WR; Bennett JM
Leuk Res; 2012 Jan; 36(1):81-6. PubMed ID: 21890199
[TBL] [Abstract][Full Text] [Related]
35. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
[TBL] [Abstract][Full Text] [Related]
36. Excessive therapeutic response in a case of blastic plasmacytoid dendritic cell neoplasm.
Shieh MP; Reisian N; Walavalkar V; Slater LM; Lambrecht N
Clin Adv Hematol Oncol; 2012 Jan; 10(1):56-9. PubMed ID: 22398810
[No Abstract] [Full Text] [Related]
37. Cutaneous blastic plasmacytoid dendritic cell neoplasm associated with anaemia and thrombocytopaenia.
Prystupa A; Wojnowska D; Skomra D; Borowiec M; Puźniak A; Lachowska-Kotowska P; Ozankaya C; Mayar A; Mosiewicz J; Chodorowska G
Acta Derm Venereol; 2009 Nov; 89(6):646-8. PubMed ID: 19997703
[No Abstract] [Full Text] [Related]
38. Blastic Plasmacytoid Dendritic Cell Neoplasm: The Dermatologist's Perspective.
Hirner JP; O'Malley JT; LeBoeuf NR
Hematol Oncol Clin North Am; 2020 Jun; 34(3):501-509. PubMed ID: 32336415
[TBL] [Abstract][Full Text] [Related]
39. CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.
Leitenberger JJ; Berthelot CN; Polder KD; Pro B; McLaughlin P; Jones D; Duvic M
J Am Acad Dermatol; 2008 Mar; 58(3):480-4. PubMed ID: 18280345
[TBL] [Abstract][Full Text] [Related]
40. Childhood blastic plasmacytoid dendritic cell neoplasm treated with allogenic stem cell transplantation.
Gambichler T; Pantelaki I; Stücker M
Pediatr Dermatol; 2013; 30(1):142-4. PubMed ID: 22300352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
